Authors: Peng, AW Hussey, EK Moore, KHP

Citation: Aw. Peng et al., A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: Effects of formulation and route of administration, J CLIN PHAR, 40(3), 2000, pp. 242-249

Authors: Peng, AW Milleri, S Stein, DS

Citation: Aw. Peng et al., Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation, ANTIM AG CH, 44(7), 2000, pp. 1974-1976

Authors: Peng, AW Hussey, EK Rosolowski, B Blumer, JL

Citation: Aw. Peng et al., Pharmacokinetics and tolerability of a single inhaled dose of zanamivir inchildren, CURR THER R, 61(1), 2000, pp. 36-46

Authors: Calfee, DP Peng, AW Hussey, EK Lobo, M Hayden, FG

Citation: Dp. Calfee et al., Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection, ANTIVIR TH, 4(3), 1999, pp. 143-149

Authors: Calfee, DP Peng, AW Cass, LM Lobo, M Hayden, FG

Citation: Dp. Calfee et al., Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection, ANTIM AG CH, 43(7), 1999, pp. 1616-1620

Authors: Fritz, RS Hayden, FG Calfee, DP Cass, LMR Peng, AW Alvord, WG Strober, W Straus, SE

Citation: Rs. Fritz et al., Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment, J INFEC DIS, 180(3), 1999, pp. 586-593